Genelux (NASDAQ:GNLX) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
0
Last 30D
0
1
0
0
0
1M Ago
1
0
0
0
0
2M Ago
1
1
0
0
0
3M Ago
0
0
0
0
0
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $29.75, a high estimate of $32.00, and a low estimate of $25.00. This current average represents a 8.46% decrease from the previous average price target of $32.50.
Exploring Analyst Ratings: An In-Depth Overview
The standing of Genelux among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Bruce Jackson
Benchmark
Lowers
Speculative Buy
$25.00
$30.00
Emily Bodnar
HC Wainwright & Co.
Maintains
Buy
$32.00
-
Bruce Jackson
Benchmark
Maintains
Speculative Buy
$30.00
-
Emily Bodnar
HC Wainwright & Co.
Lowers
Buy
$32.00
$35.00
Key Insights:
Action Taken: In response to ...Full story available on Benzinga.com
Benzinga
